Literature DB >> 21789619

IgG RF and anti-CCP2 antibody can be positive in undifferentiated arthritis due to streptococcal infection, hepatitis B virus, tuberculosis, trauma and hypothyroidism: a preliminary study.

Usha Singh1, Pamod Kumar Verma, Priyanka Bhagat, Sangeeta Singh, Suman Singh, Nand Kumar Singh.   

Abstract

Anti-CCP2 antibody and rheumatoid (RF) tests are used for the diagnosis of rheumatoid arthritis (RA). Out of these two, anti-CCP2 antibody is supposed to be more specific for RA. Aim of the study was to present 33 cases of undifferentiated arthritis (UA) in which features of RA were not present, but anti-CCP2 antibody was positive. Out of the 33 cases of UA, 19 had well-known disease like hyperthyroidism, hypothyroidism, tubercular arthritis, traumatic arthritis, pneumonia with arthritis, varicose vein with pain in legs, cervical spondylitis and SSA. The duration of disease was more than one year in 67.86% cases. Majority of the patients were females (63.64%). Knee joint involvement was seen in maximum number (i.e. 20 cases). All 33 cases were positive for anti-CCP2 Ab. Maximum number of cases (78.78%) had involvement of one or two joints. CRP positivity was seen in 23.07% cases. Morning stiffness was present in (36.36%) cases, while swelling of the joint was present in 33.33% cases. In 16 cases, only serum sample was available for further analysis. About 62.5% cases showed IgG RF positivity. Antitubercular IgM and IgG were detected in 18.75% cases; ASO was elevated in 12.5% cases, and HBs Ag was positive in 6.25% cases. None of the controls (30 cases) were positive for these infections, anti-CCP2 antibody or RF. Thus, our study concludes that chronic infections like streptococcus, hepatitis B, tuberculosis and autoimmune thyroid diseases can produce raised levels of anti-CCP2 antibody and IgG RF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21789619     DOI: 10.1007/s00296-011-1985-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  17 in total

1.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Authors:  G A Schellekens; H Visser; B A de Jong; F H van den Hoogen; J M Hazes; F C Breedveld; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-01

2.  Anticyclic citrullinated peptide autoantibodies in systemic lupus erythematosus.

Authors:  Usha Singh; Sangeeta Singh; Nand K Singh; Pramod K Verma; Suman Singh
Journal:  Rheumatol Int       Date:  2010-02-21       Impact factor: 2.631

3.  The presence of citrullinated proteins is not specific for rheumatoid synovial tissue.

Authors:  Erik R Vossenaar; Tom J M Smeets; Maarten C Kraan; Jos M Raats; Walther J van Venrooij; Paul P Tak
Journal:  Arthritis Rheum       Date:  2004-11

4.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 5.  Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.

Authors:  Walther J van Venrooij; Joyce J B C van Beers; Ger J M Pruijn
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

6.  Is rheumatoid factor still a superior test for the diagnosis of rheumatoid arthritis?

Authors:  Usha Singh; Anjali Vishwanath; Pramod K Verma; Nand K Singh; Ram C Shukla; Sangeeta Singh; Suman Singh; Gyanendra K Sonkar
Journal:  Rheumatol Int       Date:  2010-01-08       Impact factor: 2.631

7.  A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis.

Authors:  Leonid Padyukov; Camilla Silva; Patrik Stolt; Lars Alfredsson; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2004-10

Review 8.  Basic principles of nuclear medicine techniques for detection and evaluation of trauma and sports medicine injuries.

Authors:  P Matin
Journal:  Semin Nucl Med       Date:  1988-04       Impact factor: 4.446

Review 9.  Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.

Authors:  Kunihiro Nishimura; Daisuke Sugiyama; Yoshinori Kogata; Goh Tsuji; Takashi Nakazawa; Seiji Kawano; Katsuyasu Saigo; Akio Morinobu; Masahiro Koshiba; Karen M Kuntz; Isao Kamae; Shunichi Kumagai
Journal:  Ann Intern Med       Date:  2007-06-05       Impact factor: 25.391

10.  Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection.

Authors:  Sang-il Lee; Wan Hee Yoo; Hee Jin Yun; Dal Sik Kim; Hye Soo Lee; Sam Im Choi; Ji An Hur; Yong Gon Cho
Journal:  Clin Rheumatol       Date:  2006-11-29       Impact factor: 3.650

View more
  1 in total

1.  Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers.

Authors:  Ediz Dalkılıç; Mustafa Ferhat Öksüz; Ayşe Nur Tufan; Aysun Özbek; Ali Nizamoğlu; Mürside Esra Dolarslan; Belkıs Nihan Coşkun; Yavuz Pehlivan
Journal:  Eur J Rheumatol       Date:  2015-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.